Diseases
Chronic Obstructive Pulmonary Disease Market Forecast 2024-2034: Competitive Intelligence & Growth Drivers for Pharma Stakeholders
The chronic obstructive pulmonary disease (COPD) market is expected to experience steady growth in the coming years, driven primarily by increasing diagnosed prevalent cases and the introduction of novel biologics and combination therapies by key COPD companies, including Sanofi, Regeneron Pharmaceuticals, GlaxoSmithKline, AstraZeneca, and Amgen. The report forecasts that the